Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare plasma cell dyscrasia characterized by polyneuropathy, organomegaly, endocrinopathy, extravascular fluid overload, M protein, and a myriad of skin changes. The pathogenesis is poorly understood, but monoclonal plasma cells are λ-restricted and these immunoglobulin λ light chain variable (IGLV) region genes are derived from only two germlines, either IGLV1-44 or 1-40. Here we analyzed the clonal IGLV gene rearrangements of genomic DNA samples of bone marrow mononuclear cells using next-generation sequencing (NGS) to understand the clonal composition of IGLV genes in patients with POEMS syndrome (n = 30).
| INTRODUCTION
Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare paraneoplastic disorder that occurs secondary to a plasma cell dyscrasia. It is characterized by polyneuropathy, organomegaly, endocrinopathy, λ-type M protein, and a myriad of skin changes, such as hypertrichosis, skin thickening, cherry angiomata, and hyperpigmentation. 1 Other important features of the disorder include sclerotic bone lesions, extravascular fluid overload causing pleural effusions and/or ascites, papilledema, thrombocytosis, plasmacytomas, clubbing, pulmonary hypertension, multicentric Castleman disease, elevated levels of vascular endothelial growth factor (VEGF), and fatigue. 2 Until recently, treatment for POEMS syndrome was largely unsuccessful, and the prognosis was extremely poor. 3 Treatments for POEMS syndrome have focused on the underlying plasma cell disorder, and have had some success. Autologous peripheral blood stem cell transplantation (ASCT) after high-dose melphalan-based chemotherapy and novel agents used to treat multiple myeloma such as proteasome inhibitors and immunomodulatory drugs (IMiDs), have significantly improved the prognosis for patients with POEMS syndrome.
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Nevertheless, the pathogenesis of POEMS syndrome and the role of monoclonal plasma cells in the disease remain unclear. Plasma cells represent only 5% of the total nuclear cells in the bone marrow of patients with POEMS syndrome. 12 This tumor burden is lower to that in patients with multiple myeloma (MM). VEGF strongly promotes neovascularization and vasopermeability, 13 and VEGF overproduction triggers symptoms of POEMS syndrome, such as angiomata, pleural effusion/ascites, edema, polyneuropathy, and organomegaly. [14] [15] [16] [17] [18] It is presumed that VEGF is produced from or released by monoclonal plasma cells or platelets in POEMS syndrome, but this has not been confirmed. In addition, M protein is essentially a λ light chain and the immunoglobulin λ light chain variable region (IGLV) genes are highly restricted to two germline sequences, IGLV1-40 and IGLV1-44 in patients with POEMS syndrome beyond races. [19] [20] [21] However, those findings were identified using classical polymerase chain reaction (PCR)-based methods.
Next-generation sequencing (NGS) has been applied to many lymphoid malignancies, including MM, to monitor disease activity and assess the minimal residual disease (MRD). 22 NGS-based multiplex sequencing of the immunoglobulin heavy chain (IgH) in plasma cells from MM patients may have the potential to achieve a higher level of sensitivity (up to 1 × 10 6 ) with an improved quantifiable range NGS enables the analysis of genetic diversity and clonogenic heterogeneity, which can contribute to our current understanding of disease biology and relapse kinetics in patients with hematological malignancies.
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Here, we analyzed clonal IGLV gene rearrangements using an NGS-based approach to understand IGLV clonal composition in patients with POEMS syndrome. The goal of our study was to clarify the association between monoclonal plasma cells and POEMS syndrome pathogenesis. First, we excluded inappropriate sequences; particularly sequences that included stop codons, pseudogenes, and sequences that were nonfunctional due to insertions/deletions. Sequences with low V region identity (< 85%) were also excluded, as they indicated potential nucleotide insertions and/or deletions. Subsequently, we categorized each sequence by its closest matched germline sequences. Sequences that were not specific to a unique germline sequence, or not specific to IGLV1/2 or IGLV3, were categorized as "unclassified". Sequences identified as "IGLV1-36" or "IGLV1-44" were categorized as "IGLV1-36/44" as it was not possible to distinguish between IGLV1-36 and IGLV1-44 due to sequence homology in the PCR target regions. Clonotypes were defined as sharing the same IGLV germline sequence, CDR3 length, and CDR3 AA sequence. 32, 33 In each germline sequence category, the number of sequences with the same clonotype and their frequency out of sequences from all the categories were calculated. Raw data files were processed with Python (ver2.7) scripts to remove inappropriate sequences, categorize the sequences, and calculate the frequencies.
| MATERIALS AND METHODS

| Patients and preparation of BM samples
In evaluating the results, we defined "dominant clone" as the most frequently detected clonotype in each corresponding germline category. Specific cut-off is not determined to decide dominant clone. The percentage number, which demonstrates "clone size" for each clonotype, is the number that accounts for the proportion of all germline sequences. We statistically evaluated the significant increase of dominant clone size using χ 2 -test, comparing dominant clone size of each POEMS and MM samples with the mean of negative controls.
| Amplification of monoclonal IGLV gene and sequencing by heteroduplex analysis
As a control, we amplified monoclonal IGLV gene and sequenced by
Sanger method using heteroduplex (HD) analysis, as previously described. 19 Total RNA was extracted from the preserved BMMNCs at the diagnosis using Qiagen All Prep DNA/RNA Mini Kit, and singlestranded cDNA was synthesized using Takara Prime Script RT reagent mismatching causes the double helix to take on a conformation, which retards its mobility during electrophoresis. Homoduplex bands on the polyacrylamide gel were excised and PCR fragments were eluted from the gel slice using NucleoSpin Gel and PCR Clean-up (MACHEREY-NAGEL, Duren, Germany) and subjected to cycle sequencing.
Sequence data were analyzed using IMGT database.
| Statistical analysis
Comparisons between controls and samples were performed by χ Table S1 and Supporting information Figure S1 ). The IGLV gene rearrangement sequences were detected by Sanger sequencing in 22 patients as shown previously (IGLV1-40, n = 5:22.7%, IGLV1-44, n = 17:77.3%, Supporting information Table S1 and Supporting information Figure S2 ). 19 All samples with significant increase of IGLV1-36/44 by NGS were confirmed to have
IGLV1-44 as the most dominant clonotype by HD analysis and Sanger
sequencing. In 13 patients among them, the clonotypes detected by Sanger sequencing were homologous with the most dominant clonotype in NGS analysis. Notably, in three patients among these 13 cases, the most dominant clonotypes, which were detected as clonal IGLV gene rearrangements in HD analysis were not detected as "significantly increased clonal IGLV gene rearrangement" in NGS analysis.
Although Li et al. reported the relationship between clinical features
and IGLV genes, 20 there was no significant association between the IGLV gene usage and clinical features of POEMS syndrome in our study.
| The clone size of IGLV gene rearrangements is not directly linked to initial disease status in patients with POEMS syndrome
Specific clonal IGLV gene rearrangements could not be detected in some patients. The clinical characteristics of patients with and without significantly increased dominant clonal IGLV gene rearrangements were shown in Table 2 . The only factor that exerted a significant influence was age. Patients with significantly increased dominant clonal IGLV gene rearrangements were significantly younger (P = 0.03).
There were no significant differences in gender, serum VEGF level, or plasma cell content in the BM at diagnosis and it's κ/λ restriction by in situ hybridization (Table 2) . Clinical presentations and immunoglobulin heavy chain type did not show any differences (data not shown).
These results indicate that the clone size of plasma cells in the BM is not directly correlated with initial disease activity in patients with POEMS syndrome. ASCT without clinical relapse. In agreement with this observation, the clonotype frequency also slightly increased in this patient at this point; subsequently 1 year after ASCT, this patient clinically relapsed with clonotype frequency significantly increasing. In POEMS patient #25, we did not detect a significant increase in clonotype frequency at diagnosis. However, the specific IGLV1-40 clonotype increased at the time of relapse. Interestingly, this clonotype was already the most dominant clonotype at diagnosis, although it was not significantly increased at diagnosis. The frequencies of the most dominant clonotype in POEMS patients #12, #16, and #18 were low at first, and could not be detected during all courses. To be added, all patients who had repeated NGS after treatment whose clones decreased, their monoclonal proteins in their serum also turned out to be negative. These results suggest that POEMS-associated IGLV gene rearrangement clones can exist at very low levels that are impossible to detect in some cases, but they can still play a role in the pathogenesis of POEMS syndrome.
Additionally, comparing the homoduplex band of samples in clinical courses, the bands detected at diagnosis became faint at the time of remission and reappeared at the time of relapse ( Figure 2C ). These results also suggest the association between the state of POEMS syndrome and the IGLV gene rearrangements.
| DISCUSSION
POEMS syndrome was recognized as a paraneoplastic syndrome due to the underlying plasma cell disorder, but the pathogenesis of the syndrome is not well understood. The direct relationship between monoclonal plasma cells and the various manifestations of the syndrome has not been elucidated. To our knowledge, this is the first report to analyze the plasma cell clone size in patients with POEMS syndrome using NGS to understand the significance of clonal plasma cells in this disease.
We analyzed the IGLV gene rearrangement in patients with POEMS syndrome, and confirmed that clonal light chain gene usage is restricted to the IGLV1-44 and IGLV1-40 germline sequences, as others and we previously reported. [19] [20] [21] We have demonstrated a significant increase in unique IGLV gene rearrangements in patients with POEMS syndrome. In some cases, we did not detect significant differences. One possible reason is that bone marrow involvement in POEMS syndrome is usually found in 2/3 patients, and in 1/3 patients the disease is present only in focal bone lesions, therefore the frequency of the dominant clonotype was too low to be detected in some cases. From samples from patient #12, the homoduplex band could not be detected neither from sample at diagnosis and sample after ASCT. Total DNA amount for PCR was set even in each patient. HDa, heteroduplex analysis [Color figure can be viewed at wileyonlinelibrary.com] to our prediction, VEGF levels at diagnosis were not correlated with the clone sizes of IGLV gene rearrangements among our patients.
VEGF is generally expressed in plasma cells, 35, 36 megakaryocytes/ platelets, 37, 38 osteoblasts, macrophages, and tumor cells. 39 Our data indicate that VEGF may not be secreted mainly from monoclonal plasma cells in POEMS syndrome. Further investigation will be needed to clarify the source of VEGF.
In contrast, following each patient's clinical course, we could recognize that the frequency of IGLV gene rearrangements from Abbreviation: ISH, in situ hybridization.
